Lin DY - Search Results

1

Effectiveness of XBB.1.5 vaccines and antiviral drugs against severe outcomes of omicron infection in the USA.

Lin DY, Huang S, Milinovich A, Duggal A, Wang X. Lin DY, et al. Lancet Infect Dis. 2024 May;24(5):e278-e280. doi: 10.1016/S1473-3099(24)00150-6. Epub 2024 Mar 4. Lancet Infect Dis. 2024. PMID: 38452778 No abstract available.

2

Impact of Vaccination, Prior Infection, and Therapy on Omicron Infection and Mortality.

Wang X, Zein J, Ji X, Lin DY. Wang X, et al. Among authors: lin dy. J Infect Dis. 2023 Apr 18;227(8):970-976. doi: 10.1093/infdis/jiac460. J Infect Dis. 2023. PMID: 36415931 Free PMC article.

3

Effectiveness of Bebtelovimab Against Hospitalization and Death From the Omicron BA.4/BA.5 and BQ.1/BQ.1.1 Subvariants.

Wang X, Fadel FA, Huang S, Sacha GL, Bartley P, Duggal A, Lin DY. Wang X, et al. Among authors: lin dy. Chest. 2023 Oct;164(4):872-874. doi: 10.1016/j.chest.2023.06.004. Epub 2023 Jun 17. Chest. 2023. PMID: 37414096 No abstract available.

4

Nirmatrelvir or Molnupiravir Use and Severe Outcomes From Omicron Infections.

Lin DY, Abi Fadel F, Huang S, Milinovich AT, Sacha GL, Bartley P, Duggal A, Wang X. Lin DY, et al. JAMA Netw Open. 2023 Sep 5;6(9):e2335077. doi: 10.1001/jamanetworkopen.2023.35077. JAMA Netw Open. 2023. PMID: 37733342 Free PMC article.

5

Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA: an observational cohort study.

Lin DY, Xu Y, Gu Y, Zeng D, Wheeler B, Young H, Moore Z, Sunny SK. Lin DY, et al. Lancet Infect Dis. 2023 Nov;23(11):1257-1265. doi: 10.1016/S1473-3099(23)00272-4. Epub 2023 Jun 16. Lancet Infect Dis. 2023. PMID: 37336222 Free PMC article.

6

Effectiveness of Bivalent Boosters against Severe Omicron Infection.

Lin DY, Xu Y, Gu Y, Zeng D, Wheeler B, Young H, Sunny SK, Moore Z. Lin DY, et al. N Engl J Med. 2023 Feb 23;388(8):764-766. doi: 10.1056/NEJMc2215471. Epub 2023 Jan 25. N Engl J Med. 2023. PMID: 36734847 Free PMC article. No abstract available.

7

Bivalent Boosters against Severe Omicron Infection. Reply.

Lin DY. Lin DY. N Engl J Med. 2023 May 4;388(18):1726-1727. doi: 10.1056/NEJMc2303753. N Engl J Med. 2023. PMID: 37133607 No abstract available.

8

More on Omicron Infections in Children. Reply.

Lin DY. Lin DY. N Engl J Med. 2022 Nov 17;387(20):1911-1912. doi: 10.1056/NEJMc2212691. N Engl J Med. 2022. PMID: 36383728 No abstract available.

9

Durability of Bivalent Boosters against Omicron Subvariants.

Lin DY, Xu Y, Gu Y, Zeng D, Sunny SK, Moore Z. Lin DY, et al. N Engl J Med. 2023 May 11;388(19):1818-1820. doi: 10.1056/NEJMc2302462. Epub 2023 Apr 12. N Engl J Med. 2023. PMID: 37043647 Free PMC article. No abstract available.

10

A Cost-Benefit Analysis of Bivalent Covid-19 Vaccines.

Lin DY, Xu Y, Zeng D, Sunny SK. Lin DY, et al. J Biotechnol Biomed. 2023;6(4):551-553. doi: 10.26502/jbb.2642-91280116. Epub 2023 Nov 1. J Biotechnol Biomed. 2023. PMID: 38050633 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

554 results

Search Page